We only have this paper's title and publication details.
Read it at the sourceCIVO Phase 0 trial reveals proinflammatory effects of dazostinag on the tumor microenvironment in patients with head and neck squamous cell carcinoma, highlighting its potential role in chemotherapy.
Figure S1. CIVO Phase 0 clinical workflow
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: